Document is current

Any future updates will be listed below

Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2V617F-induced myeloproliferative neoplasms

Crossref DOI link: https://doi.org/10.1038/s41408-024-01058-y

Published Online: 2024-06-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark